Cargando…

Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes

BACKGROUND: Resistant ovary syndrome (ROS) is a rare endocrine disorder characterized with hypergonadotrophic hypogonadism. Infertility is a common complaint of woman presenting with ROS, and little progress has been made in term of reproduction with the patient’s own gamete. So far only one case re...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yu, Pan, Ping, Yuan, Ping, Qiu, Qi, Yang, Dongzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012097/
https://www.ncbi.nlm.nih.gov/pubmed/27599836
http://dx.doi.org/10.1186/s13048-016-0263-6
_version_ 1782451957268480000
author Li, Yu
Pan, Ping
Yuan, Ping
Qiu, Qi
Yang, Dongzi
author_facet Li, Yu
Pan, Ping
Yuan, Ping
Qiu, Qi
Yang, Dongzi
author_sort Li, Yu
collection PubMed
description BACKGROUND: Resistant ovary syndrome (ROS) is a rare endocrine disorder characterized with hypergonadotrophic hypogonadism. Infertility is a common complaint of woman presenting with ROS, and little progress has been made in term of reproduction with the patient’s own gamete. So far only one case report of live birth has been reported after in vitro maturation (IVM) of oocytes in a patient suffering from ROS in 2013. CASE PRESENTATION: A secondary infertile woman of 33 years-old was manifested with oligomenorrhea and markedly increased gonadotropin levels around postmenopausal range, but had normal antral follicle count, normal serum inhibin B and anti-Müllerian hormone levels. She had normal karyotype of 46,XX and normal thyroid function. There were no abnormal findings in some autoantibody assays and FSH receptor sequencing. After oral contraceptive pills combined with triptorelin depot were administered, her gonadotropin levels reduced but it showed no response to high doses of exogenous gonadotropins (hp-HMG 300IU/d for 15 days). Then endometrium was prepared with estradiol valerate and IVM from small antral follicles were performed. Five immature oocytes were retrieved. Twenty-four hours after IVM culture, 3 oocytes matured to metaphase II stage and were inseminated by intracytoplasmic sperm injection using her husband’s sperm. Two top-quality embryos were transferred and one embryo was cryopreserved. The patient got pregnant and delivered a healthy boy at term. CONCLUSION: IVM using their own oocytes could be an available treatment for infertile women with ROS.
format Online
Article
Text
id pubmed-5012097
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50120972016-09-07 Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes Li, Yu Pan, Ping Yuan, Ping Qiu, Qi Yang, Dongzi J Ovarian Res Case Report BACKGROUND: Resistant ovary syndrome (ROS) is a rare endocrine disorder characterized with hypergonadotrophic hypogonadism. Infertility is a common complaint of woman presenting with ROS, and little progress has been made in term of reproduction with the patient’s own gamete. So far only one case report of live birth has been reported after in vitro maturation (IVM) of oocytes in a patient suffering from ROS in 2013. CASE PRESENTATION: A secondary infertile woman of 33 years-old was manifested with oligomenorrhea and markedly increased gonadotropin levels around postmenopausal range, but had normal antral follicle count, normal serum inhibin B and anti-Müllerian hormone levels. She had normal karyotype of 46,XX and normal thyroid function. There were no abnormal findings in some autoantibody assays and FSH receptor sequencing. After oral contraceptive pills combined with triptorelin depot were administered, her gonadotropin levels reduced but it showed no response to high doses of exogenous gonadotropins (hp-HMG 300IU/d for 15 days). Then endometrium was prepared with estradiol valerate and IVM from small antral follicles were performed. Five immature oocytes were retrieved. Twenty-four hours after IVM culture, 3 oocytes matured to metaphase II stage and were inseminated by intracytoplasmic sperm injection using her husband’s sperm. Two top-quality embryos were transferred and one embryo was cryopreserved. The patient got pregnant and delivered a healthy boy at term. CONCLUSION: IVM using their own oocytes could be an available treatment for infertile women with ROS. BioMed Central 2016-09-06 /pmc/articles/PMC5012097/ /pubmed/27599836 http://dx.doi.org/10.1186/s13048-016-0263-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Li, Yu
Pan, Ping
Yuan, Ping
Qiu, Qi
Yang, Dongzi
Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes
title Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes
title_full Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes
title_fullStr Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes
title_full_unstemmed Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes
title_short Successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes
title_sort successful live birth in a woman with resistant ovary syndrome following in vitro maturation of oocytes
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012097/
https://www.ncbi.nlm.nih.gov/pubmed/27599836
http://dx.doi.org/10.1186/s13048-016-0263-6
work_keys_str_mv AT liyu successfullivebirthinawomanwithresistantovarysyndromefollowinginvitromaturationofoocytes
AT panping successfullivebirthinawomanwithresistantovarysyndromefollowinginvitromaturationofoocytes
AT yuanping successfullivebirthinawomanwithresistantovarysyndromefollowinginvitromaturationofoocytes
AT qiuqi successfullivebirthinawomanwithresistantovarysyndromefollowinginvitromaturationofoocytes
AT yangdongzi successfullivebirthinawomanwithresistantovarysyndromefollowinginvitromaturationofoocytes